ATE229968T1 - Diagnostisches mittel zur glykostoffwechselfunktion - Google Patents

Diagnostisches mittel zur glykostoffwechselfunktion

Info

Publication number
ATE229968T1
ATE229968T1 AT97302141T AT97302141T ATE229968T1 AT E229968 T1 ATE229968 T1 AT E229968T1 AT 97302141 T AT97302141 T AT 97302141T AT 97302141 T AT97302141 T AT 97302141T AT E229968 T1 ATE229968 T1 AT E229968T1
Authority
AT
Austria
Prior art keywords
glycosto
diagnostic agents
metabolic function
acyl
carbon atoms
Prior art date
Application number
AT97302141T
Other languages
English (en)
Inventor
Yasuhisa Fujibayashi
Atsuo Waki
Akira Yokoyama
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Application granted granted Critical
Publication of ATE229968T1 publication Critical patent/ATE229968T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104998—Glucose, ketone, nitrate standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
    • Y10T436/144444—Glucose

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97302141T 1996-03-28 1997-03-27 Diagnostisches mittel zur glykostoffwechselfunktion ATE229968T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9925296 1996-03-28

Publications (1)

Publication Number Publication Date
ATE229968T1 true ATE229968T1 (de) 2003-01-15

Family

ID=14242525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97302141T ATE229968T1 (de) 1996-03-28 1997-03-27 Diagnostisches mittel zur glykostoffwechselfunktion

Country Status (7)

Country Link
US (1) US5904915A (de)
EP (1) EP0798309B1 (de)
AT (1) ATE229968T1 (de)
DE (1) DE69717895T2 (de)
DK (1) DK0798309T3 (de)
ES (1) ES2190797T3 (de)
PT (1) PT798309E (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6773669B1 (en) 1995-03-10 2004-08-10 Maxcyte, Inc. Flow electroporation chamber and method
KR100430061B1 (ko) * 2000-03-21 2004-05-03 재단법인 아산사회복지재단 글루코스 유도체에 방사성 동위원소가 표지된 착화합물 및이를 생산하기 위한 조성물이 포함된 키트
US7029916B2 (en) 2001-02-21 2006-04-18 Maxcyte, Inc. Apparatus and method for flow electroporation of biological samples
EP2574662B1 (de) 2001-08-22 2021-08-04 Maxcyte, Inc. Verfahren zur Elektroporation biologischer Proben
EP1660519B1 (de) * 2003-07-29 2014-05-14 Immunomedics, Inc. Konjugate von 2-[18F]Fluor-2-desoxy-D-glucose und einem Peptid-Molekül
CA2565316C (en) 2004-05-12 2017-05-30 Maxcyte, Inc. Methods and devices related to a regulated flow electroporation chamber
WO2006127842A2 (en) * 2005-05-23 2006-11-30 The Regents Of The University Of California Tracers for monitoring the activity of sodium/glucose cotransporters in health and disease
JP2009543862A (ja) 2006-07-14 2009-12-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ガンのバイオマーカーおよびその使用方法
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
EP2564200B8 (de) 2010-04-27 2019-10-02 The Regents of The University of California Krebsbiomarker und anwendungsverfahren dafür
US20140271474A1 (en) * 2011-06-14 2014-09-18 The Regents Of The University Of California Inhibitor probes for imaging sodium-glucose cotransporters in health and disease
WO2016090323A1 (en) 2014-12-05 2016-06-09 Prelude, Inc. Dcis recurrence and invasive breast cancer
JP2022500504A (ja) 2018-09-14 2022-01-04 プレリュード コーポレーションPrelude Corporation 浸潤性乳癌のリスクを有する対象の治療の選択方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2817336C2 (de) * 1978-04-20 1984-08-23 Institute of Whole Body Metabolism, Hachioji, Tokyo Röntgenkontrastmittel und ein dieses enthaltendes diagnostisches Mittel
JP2690018B2 (ja) * 1989-07-13 1997-12-10 日本メジフィジックス株式会社 グルコサミン誘導体よりなる放射性診断剤
JP3645580B2 (ja) * 1993-10-22 2005-05-11 株式会社フジモト・ブラザーズ グルコースエステル誘導体を含有する脳代謝改善剤
JP3704173B2 (ja) * 1994-02-14 2005-10-05 日本メジフィジックス株式会社 グルコース誘導体

Also Published As

Publication number Publication date
DE69717895D1 (de) 2003-01-30
PT798309E (pt) 2003-03-31
DK0798309T3 (da) 2003-03-31
EP0798309B1 (de) 2002-12-18
DE69717895T2 (de) 2003-11-13
EP0798309A1 (de) 1997-10-01
US5904915A (en) 1999-05-18
ES2190797T3 (es) 2003-08-16

Similar Documents

Publication Publication Date Title
LU88712I2 (fr) TAXOTERE-Décotaxel
ATE229968T1 (de) Diagnostisches mittel zur glykostoffwechselfunktion
ATE332888T1 (de) Sphingosinderivate und medizinische zubereitung
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
SE8301395L (sv) Kelatiserande foreningar med funktionella grupper vilka tillater kovalent koppling till bio-organiska molekyler
NO962059L (no) Antiarytmiske benzodiazepiner
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
DE69122805T2 (de) Antivirusmittel
FI104178B1 (fi) 17-spirofuran-3'-ylideenisteroidit
KR960006915A (ko) 췌장염의 치료 조성물
ES2094136T3 (es) Intermediarios quirales de 1,5-diyodo-2-metoxi o benciloxi.
DE69118064T2 (de) Diamino-s-Triazinonderivate und diese enthaltende selbstlöschende polymere Zusammensetzungen
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
FR2726271B1 (fr) Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole
DK0625520T3 (da) Thiazolotriazol- og thiazolodiazolderivater med fungicid aktivitet
ATE72445T1 (de) 4'-epi-4'-aminoanthracycline.
BR9901201A (pt) Composto de titanato
DE69420514T2 (de) Cyclopropan-Derivate und diese enthaltende antivirale Mittel
ATE73136T1 (de) Verfahren zur herstellung von 6alpha, 9alphadifluor-11beta, 17alpha-dihydroxy-16alpha-methyl4-pregnen-3,20-dion und dessen derivate.
DE69711506T2 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
KR900003196A (ko) 뉴클레오티드 유도체
ATE163005T1 (de) Saintopin derivate
KR890001956A (ko) 안식향산 유도체
DE69112967D1 (de) Mitomycinderivate.
DE9312655U1 (de) Kommode, insbesondere für Kinderzimmer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0798309

Country of ref document: EP

REN Ceased due to non-payment of the annual fee